Predictive Oncology Inc. financial data

Symbol
POAI on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
91 43 Rd Street, Suite 110, Pittsburgh, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Precision Therapeutics Inc. (to 6/4/2019), Skyline Medical Inc. (to 2/6/2018), BioDrain Medical, Inc. (to 8/7/2013)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 122 % -67.4%
Quick Ratio 11.5 % +7.08%
Debt-to-equity 240 % +401%
Return On Equity -511 % -386%
Return On Assets -151 % -112%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.93M shares +120%
Common Stock, Shares, Outstanding 6.67M shares +64.1%
Entity Public Float 5.82M USD -69.3%
Common Stock, Value, Issued 66.7K USD +64.1%
Weighted Average Number of Shares Outstanding, Basic 5.45M shares +35.8%
Weighted Average Number of Shares Outstanding, Diluted 5.45M shares +35.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 122K USD -61.8%
Selling and Marketing Expense 1.47M USD -1.41%
General and Administrative Expense 7.42M USD -11.5%
Operating Income (Loss) -10.9M USD +9.72%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -12.7M USD +9.44%
Earnings Per Share, Basic -2.32 USD/shares +33.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 735K USD -91.6%
Accounts Receivable, after Allowance for Credit Loss, Current 746K USD +169%
Inventory, Net 386K USD -19.8%
Assets, Current 2.23M USD -77.9%
Property, Plant and Equipment, Net 369K USD -24.8%
Operating Lease, Right-of-Use Asset 2.06M USD -20.5%
Intangible Assets, Net (Excluding Goodwill) 210K USD -12.9%
Other Assets, Noncurrent 103K USD -2.84%
Assets 4.97M USD -65.5%
Accounts Payable, Current 1.14M USD -14.3%
Accrued Liabilities, Current 1.41M USD -8.75%
Contract with Customer, Liability, Current 305K USD +0.82%
Liabilities, Current 3.59M USD -9.05%
Operating Lease, Liability, Noncurrent 1.56M USD -26.9%
Other Liabilities, Noncurrent 23.5K USD +330%
Liabilities 5.18M USD -15.8%
Retained Earnings (Accumulated Deficit) -180M USD -7.55%
Stockholders' Equity Attributable to Parent -203K USD -102%
Liabilities and Equity 4.97M USD -65.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.42M USD +0.34%
Net Cash Provided by (Used in) Financing Activities -112K USD
Net Cash Provided by (Used in) Investing Activities -3.03K USD +93.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.53M USD -1.64%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.74K USD
Deferred Tax Assets, Valuation Allowance 27.1M USD +10.3%
Deferred Tax Assets, Gross 27.6M USD +9.41%
Operating Lease, Liability 2.13M USD -21.3%
Depreciation 136K USD -37.9%
Payments to Acquire Property, Plant, and Equipment 3.03K USD -87.6%
Lessee, Operating Lease, Liability, to be Paid 2.57M USD -25.5%
Property, Plant and Equipment, Gross 2.41M USD -8.64%
Operating Lease, Liability, Current 573K USD +28.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 804K USD -6.29%
Lessee, Operating Lease, Liability, to be Paid, Year One 798K USD -2.47%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 438K USD -40.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 828K USD +3.01%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 139K USD -83.2%
Additional Paid in Capital 180M USD +2.37%
Amortization of Intangible Assets 26.5K USD +0.09%
Depreciation, Depletion and Amortization 163K USD -31.7%
Share-based Payment Arrangement, Expense 1.12K USD -4.28%